Emergent BioSolutions Inc. — Director's Dealing 2019

May 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2019-05-23

Reporting Person: SULLIVAN LOUIS W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-23	Common Stock	A	5736	—	Acquired	60466	Direct

Footnotes

F1: Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan.

F2: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.